A Double-blind, Placebo-controlled, Randomized INTerventional Clinical Trial (SARA-INT)

PHASE2CompletedINTERVENTIONAL
Enrollment

233

Participants

Timeline

Start Date

February 7, 2017

Primary Completion Date

April 26, 2020

Study Completion Date

April 26, 2020

Conditions
SarcopeniaGait Disorders in Old AgeMuscle Weakness
Interventions
DRUG

BIO101

Oral capsules

DRUG

Placebo

Oral capsules

Trial Locations (22)

1090

Vrije Universiteit Brussel, Brussels

3000

Universitaire Ziekenhuizen (UZ) Leuven - Gasthuisberg - Centrum voor metabole botziekten, Leuven

4020

Université de Liège, Liège

10032

Columbia University, New York

27101

Bowman Gray Center for Medical Education-of- Wake Forest School of Medicine, Winston-Salem

28401

PMJ Research of Wilmington, Wilmington

32209

Jax-Ascent University of Florida, Jacksonville

32611

Institut On Aging, Gainesville

33014

PANAX Clinical Research, Miami Lakes

33563

Clinical Research of Central Florida, Plant City

70808

Pennington Biomedical Research Center, Baton Rouge

73099

Tekton Research, Yukon

77030

Medical Center, Houston

78229

Science Advancing Medicine Clinical Research Center, San Antonio

78245

The University of Texas Health Science Center at San Antonio, San Antonio

78745

Tekton Research, Austin

84088

Advanced Clinical Research, West Jordan

87106

New Mexico Clinical Research & Osteoporosis Center, Albuquerque

92123

California Research Foundation, San Diego

92221

Advanced Clinical Research, Banning

92844

SC Clinical Research, Inc, Garden Grove

02111

Jean Mayer USDA Human Nutrition research Center on Aging Tufts University, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biophytis

INDUSTRY